Morin (C5297): Natural Flavonoid Antioxidant and Mitochondrial Energy Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a natural flavonoid antioxidant sourced from Maclura pomifera and supplied by APExBIO (C5297) at ≥96.81% purity (Morin product page). It inhibits adenosine 5′-monophosphate deaminase (AMPD), thereby protecting mitochondrial energy metabolism in models of diabetic and fructose-induced podocyte injury (Yang et al., 2025). Morin acts as a fluorescent aluminum ion probe, supporting its use in metal detection workflows. It is insoluble in water but soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), with solutions recommended for short-term use. Peer-reviewed evidence confirms Morin’s efficacy in modulating biological pathways in diabetes, cancer, and neurodegenerative disease models (DOI).

Biological Rationale

Morin is a polyphenolic flavonoid characterized by its five hydroxyl groups and chromen backbone. Its antioxidant properties stem from electron-donating hydroxyl groups, facilitating neutralization of reactive oxygen species (ROS) in cellular models (Yang et al., 2025). Morin is found naturally in Maclura pomifera fruits, and its molecular weight is 302.24 Da (APExBIO). This compound is of translational interest due to its ability to modulate inflammation, oxidative stress, and mitochondrial dysfunction—key processes in diabetes, cancer, and neurodegenerative diseases (Amyloid.co article). Unlike simple antioxidants, Morin targets specific enzymes such as AMPD, altering the purine nucleotide cycle (PNC) and thus affecting energy metabolism in disease-relevant cells (PLX4720 article). This article extends previous overviews by focusing on atomic mechanism and peer-reviewed in vivo benchmarks.

Mechanism of Action of Morin

Morin’s primary mechanism involves competitive inhibition of adenosine 5′-monophosphate deaminase (AMPD), especially the AMPD2 isoform expressed in podocytes and renal cortex (Yang et al., 2025). AMPD catalyzes the deamination of AMP to IMP within the purine nucleotide cycle, regulating ATP balance and glycolytic flux. In fructose-induced podocyte injury models, Morin binding to AMPD2 was confirmed via molecular docking assays, with strong affinity and inhibition of enzymatic activity. This suppression of AMPD activity alleviates mitochondrial dysfunction, as measured by improved basal oxygen consumption rate (OCR), ATP generation, and maximal respiration in podocyte cultures exposed to 5 mM fructose for 24–48 hours. The resulting cellular protection includes reduced podocyte foot process effacement and restoration of synaptopodin expression in rat models on high-fructose diets. Morin also exerts anti-inflammatory and anti-apoptotic effects by modulating signaling pathways implicated in diabetic nephropathy and other chronic diseases (RPL3-Peptide.com article).

Evidence & Benchmarks

• Morin inhibits AMPD activity in the renal cortex of rats fed high-fructose diets, leading to improvement in glomerular podocyte ultrastructure and decreased urinary albumin-to-creatinine ratio (UACR) (Yang et al., 2025).
• In vitro, Morin (10–50 μM, 24 h) reduces fructose-induced AMPD activity and preserves mitochondrial function in mouse podocyte clone-5 (MPC5) cells (DOI).
• Molecular docking demonstrates strong binding affinity of Morin to the AMPD2 isoform, supporting its mechanism as a direct enzyme inhibitor (DOI).
• Morin’s purity (≥96.81%) is verified by HPLC, MS, and NMR, ensuring batch reproducibility for biochemical assays (APExBIO).
• Fluorescent chelation of aluminum ions by Morin is validated for probe applications, with high selectivity under buffered pH (7.4) conditions (PLX4720 article: fluorescent probe).
• Morin is insoluble in water but fully soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), enabling flexible formulation for cell-based and biochemical workflows (APExBIO).
• Morin also exhibits anti-inflammatory, cardioprotective, and neuroprotective effects in preclinical models, though mechanism specificity may differ by disease context (TRAF2.com article).

Applications, Limits & Misconceptions

Morin is deployed in models of diabetes, cancer, and neurodegenerative disease for its antioxidant, anti-inflammatory, and mitochondrial-modulating effects. Its ability to inhibit AMPD and modulate the purine nucleotide cycle enables unique interrogation of energy metabolism disturbances, particularly in cell types with high ATP turnover (e.g., podocytes, neurons). As a fluorescent chelator, Morin is useful in detecting aluminum ions in environmental and biological samples, supporting dual utility in analytical and mechanistic workflows (PLX4720: fluorescent probe).

Common Pitfalls or Misconceptions

• Morin is not water-soluble; aqueous stock solutions are unstable and may precipitate. Use DMSO or ethanol for stock preparation (APExBIO).
• Morin’s AMPD inhibition is isoform-specific (highest for AMPD2). Effects in tissues dominated by other AMPD isoforms may differ (Yang et al., 2025).
• Cellular protective effects are context-dependent; not all cancer or neurodegenerative models show equal responsiveness (TRAF2.com).
• Morin’s fluorescent probe activity is selective for Al³⁺, and is not a general indicator for all metal ions (PLX4720 article).
• Long-term storage of Morin solutions is not recommended; prepare fresh aliquots for each experiment to ensure reproducibility (APExBIO).

Workflow Integration & Parameters

For in vitro studies, dissolve Morin in DMSO at up to 19.53 mg/mL. Working concentrations typically range from 5–50 μM, depending on cell type and exposure duration (e.g., 24–48 h for mitochondrial assays). For in vivo rodent models, consult published protocols—recent studies used dietary supplementation or i.p. injection (1–10 mg/kg/day) to assess renal and metabolic endpoints (Yang et al., 2025). For biochemical aluminum ion probe assays, buffer Morin at pH 7.4 and titrate with Al³⁺ to measure fluorescence emission shifts. Always store powder at −20°C in a desiccated environment, and avoid repeated freeze-thaw cycles. The C5297 kit from APExBIO is validated for batch-to-batch consistency, supporting reproducible translational workflows (APExBIO product page).

This article extends the mechanistic scope established in Amyloid.co by specifying solubility limits and newly-verified mitochondrial benchmarks, and clarifies workflow parameters relative to PLX4720.com by emphasizing AMPD isoform specificity and in vivo podocyte protection data.

Conclusion & Outlook

Morin (C5297, APExBIO) is a rigorously characterized, high-purity flavonoid compound with proven antioxidant, mitochondrial, and enzyme-inhibitory effects across diabetes, cancer, and neurodegenerative disease models (Yang et al., 2025). Its competitive inhibition of AMPD, particularly AMPD2, positions Morin as both a mechanistic research tool and a workflow-validated biochemical probe. Continued development of Morin-based assays may further elucidate mitochondrial energy regulation and disease-modifying interventions. Practitioners should adhere to solubility and storage best practices to ensure experimental fidelity.